The drug generated $4.4 billion in the first 9 months of 2024, but BMS expects an "additional step down” to $2 billion to $2.5 billion in 2025. In addition, Pomalyst and Sprycel are expected to ...

While the New Year's tradition of drug price hikes has held firm for years, pharma companies have decidedly tamped down on the magnitude of cost increases getting rolled out Jan. 1. All told ...

LGES, Qualcomm in BMS technology partnership. LG Energy Solution Ltd (LGES) officially launched its new advanced system-on-chip (SoC)-based battery management system (BMS) with diagnostic ...